You are here

orforglipron

Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s

Yahoo/Bloomberg

Thu, 04/17/25 - 11:34 am

clinical trials

Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile

US News and World Report

Thu, 02/20/25 - 06:07 pm

clinical trials

3 trial readouts that could shake up the obesity market this year

Pharma Voice

Wed, 01/8/25 - 11:15 am

Skye Bioscience

clinical trials

Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025

Motley Fool

Thu, 12/12/24 - 11:41 pm

Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle

Fierce Biotech

Mon, 06/26/23 - 10:00 am

ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer

EP Vantage

Wed, 06/21/23 - 10:38 am

Lilly steps up its oral obesity push

EP Vantage

Thu, 05/25/23 - 08:45 pm

Lilly and Pfizer fight for new territory in obesity and diabetes

EP Vantage

Thu, 12/15/22 - 10:46 am